NEWS & MEDIA
August 1, 2023
ACTUATE THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR ELRAGLUSIB FOR TREATMENT OF PANCREATIC CANCER
March 23, 2023
ACTUATE THERAPEUTICS’ CONGRATULATES DR. PATRICIA LORUSSO ON BEING NAMED AACR PRESIDENT-ELECT
October 18, 2022
DRS. ROGER B. COHEN, LEE M. ELLIS AND JOHN L. MARSHALL JOIN ACTUATE THERAPEUTICS’ SCIENTIFIC ADVISORY BOARD
October 28, 2021
ACTUATE THERAPEUTICS ANNOUNCES PRIMARY ENDPOINT MET IN PHASE 2 STUDY IN PANCREATIC CANCER
PARTNERING
As we continue to develop novel therapies to improve outcomes for patients. We are open to new partnerships with academic and scientific organizations.